196 related articles for article (PubMed ID: 19738550)
1. Calcitriol (Vectical) for mild to moderate plaque psoriasis.
Med Lett Drugs Ther; 2009 Sep; 51(1320):70-1. PubMed ID: 19738550
[TBL] [Abstract][Full Text] [Related]
2. Calcitriol ointment: a review of a topical vitamin D analog for psoriasis.
Sigmon JR; Yentzer BA; Feldman SR
J Dermatolog Treat; 2009; 20(4):208-12. PubMed ID: 19444692
[TBL] [Abstract][Full Text] [Related]
3. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
Lebwohl M; Menter A; Weiss J; Clark SD; Flores J; Powers J; Balin AK; Kempers S; Glinert RJ; Fleming T; Liu Y; Graeber M; Pariser DM
J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis.
Kircik L
J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s9-16. PubMed ID: 19702031
[TBL] [Abstract][Full Text] [Related]
5. Calcitriol ointment: optimizing psoriasis therapy.
Gold LF
J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s23-7. PubMed ID: 19702033
[TBL] [Abstract][Full Text] [Related]
6. Calcitriol 3 microg/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy.
Abramovits W
J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s17-22. PubMed ID: 19702032
[TBL] [Abstract][Full Text] [Related]
7. New drug information. Vectical ointment.
Physician Assistants' Prescribing Reference
JAAPA; 2009 May; 22(5):14. PubMed ID: 19469384
[No Abstract] [Full Text] [Related]
8. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
[TBL] [Abstract][Full Text] [Related]
9. Calcitriol ointment 3 microg/g is safe and effective over 52 weeks for the treatment of mild to moderate plaque psoriasis.
Lebwohl M; Ortonne JP; Andres P; Briantais P
Cutis; 2009 Apr; 83(4):205-12. PubMed ID: 19445311
[TBL] [Abstract][Full Text] [Related]
10. Topical use of calcitriol 3 microg/g ointment in the treatment of mild-to-moderate psoriasis: results from an open-label study.
Carboni I; de Felice C; Bergamin A; Chimenti S
J Eur Acad Dermatol Venereol; 2005 Nov; 19 Suppl 3():11-3. PubMed ID: 16274406
[TBL] [Abstract][Full Text] [Related]
11. Rheological properties of three different vitamin D ointments and their clinical perception by patients with mild to moderate psoriasis.
Marty JP; Lafforgue C; Grossiord JL; Soto P
J Eur Acad Dermatol Venereol; 2005 Nov; 19 Suppl 3():7-10. PubMed ID: 16274405
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, randomized quantitative comparison of calcitriol ointment and calcipotriol ointment on epidermal cell populations, proliferation and differentiation.
Körver JE; Vissers WH; van Rens DW; Pasch MC; van Erp PE; Boezeman JB; van De Kerkhof PC
Br J Dermatol; 2007 Jan; 156(1):130-7. PubMed ID: 17199579
[TBL] [Abstract][Full Text] [Related]
13. [New ointment with vitamin D derivative and corticoid. Psoriasis therapy combined].
MMW Fortschr Med; 2003 Jan; 145(5):56. PubMed ID: 12619221
[No Abstract] [Full Text] [Related]
14. Hypercalcemia caused by vitamin D3 analogs in psoriasis treatment.
Braun GS; Witt M; Mayer V; Schmid H
Int J Dermatol; 2007 Dec; 46(12):1315-7. PubMed ID: 18173537
[No Abstract] [Full Text] [Related]
15. Efficacy of 1, alpha 25-dihidroxyvitamin D (Calcitriol) in the treatment of psoriasis vulgaris: an open study.
Lugo-Somolinos A; Sánchez JL; Haddock L
Bol Asoc Med P R; 1990 Oct; 82(10):450-3. PubMed ID: 2080957
[TBL] [Abstract][Full Text] [Related]
16. Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression.
Vissers WH; van Vlijmen I; van Erp PE; de Jong EM; van de Kerkhof PC
Br J Dermatol; 2008 Apr; 158(4):705-12. PubMed ID: 18284400
[TBL] [Abstract][Full Text] [Related]
17. Topical calcitriol is degraded by ultraviolet light.
Lebwohl M; Quijije J; Gilliard J; Rollin T; Watts O
J Invest Dermatol; 2003 Sep; 121(3):594-5. PubMed ID: 12925220
[TBL] [Abstract][Full Text] [Related]
18. [Topical treatments for psoriasis in 2009].
Thielen AM; Laffitte E
Rev Med Suisse; 2009 Apr; 5(200):876, 878-81. PubMed ID: 19438087
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness model of topical treatment of mild to moderate psoriasis vulgaris in Germany. A comparison of calcipotriol/betamethasone (Daivobet/Dovobet/Taclonex) once daily and a morning/evening non-fix combination of calcipotriol and betamethasone.
Augustin M; Peeters P; Radtke M; Moehling U; Lapp C
Dermatology; 2007; 215(3):219-28. PubMed ID: 17823519
[TBL] [Abstract][Full Text] [Related]
20. Generalized pustular psoriasis precipitated by topical calcipotriol ointment.
Tamiya H; Fukai K; Moriwaki K; Ishii M
Int J Dermatol; 2005 Sep; 44(9):791-2. PubMed ID: 16135156
[No Abstract] [Full Text] [Related]
[Next] [New Search]
